Market closedNon-fractional
Dyadic International/DYAI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Dyadic International
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Ticker
DYAI
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Jupiter, United States
Employees
7
Website
www.dyadic.com
DYAI Metrics
BasicAdvanced
$42M
Market cap
-
P/E ratio
-$0.27
EPS
0.63
Beta
-
Dividend rate
Price and volume
Market cap
$42M
Beta
0.63
Financial strength
Current ratio
5.544
Quick ratio
5.437
Long term debt to equity
130.726
Total debt to equity
131.824
Interest coverage (TTM)
-254.87%
Management effectiveness
Return on assets (TTM)
-40.56%
Return on equity (TTM)
-102.46%
Valuation
Price to revenue (TTM)
18.398
Price to book
9.38
Price to tangible book (TTM)
9.38
Price to free cash flow (TTM)
-7.341
Growth
Revenue change (TTM)
-30.82%
Earnings per share change (TTM)
-5.36%
3-year revenue growth
8.89%
3-year earnings per share growth
-10.39%
What the Analysts think about DYAI
Analyst Ratings
Majority rating from 1 analysts.
DYAI Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$300K
-50.00%
Net income
-$2M
-0.00%
Profit margin
-666.66%
100.00%
DYAI Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 22
Q2 23
Q3 23
Q4 23
Q2 24
Actual
-$0.07
-$0.07
-$0.06
-$0.08
-
Expected
-$0.09
-$0.05
-$0.06
-$0.07
-$0.07
Surprise
-17.65%
40.00%
0.00%
23.08%
-
DYAI News
AllArticlesVideos
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
GlobeNewsWire·1 week ago
Dyadic to Attend Industry Events in June
GlobeNewsWire·1 month ago
Dyadic International, Inc. (DYAI) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Dyadic International stock?
Dyadic International (DYAI) has a market cap of $42M as of July 06, 2024.
What is the P/E ratio for Dyadic International stock?
The price to earnings (P/E) ratio for Dyadic International (DYAI) stock is 0 as of July 06, 2024.
Does Dyadic International stock pay dividends?
No, Dyadic International (DYAI) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Dyadic International dividend payment date?
Dyadic International (DYAI) stock does not pay dividends to its shareholders.
What is the beta indicator for Dyadic International?
Dyadic International (DYAI) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Dyadic International stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.